Iovance Biotherapeutics (IOVA) Invested Capital (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Invested Capital of $250000.0 for Q4 2012, little changed quarter-over-quarter from $250000.0 in Q3 2012.
Analysis
Iovance Biotherapeutics (IOVA) Invested Capital (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Invested Capital for 1 consecutive years, with $250000.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Invested Capital changed N/A year-over-year to $250000.0; the TTM figure through Mar 2015 stood at $250000.0 (changed N/A YoY), while the FY2012 annual figure was $250000.0, changed N/A from the prior year.
- Invested Capital was little changed at $250000.0 in Q4 2012 per IOVA's latest filing, from $250000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $250000.0 in Q3 2012 and bottomed at $250000.0 in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 722.75 Mn |
| Dec 31, 2025 | 699.58 Mn |
| Sep 30, 2025 | 703.29 Mn |
| Jun 30, 2025 | 699.49 Mn |
| Mar 31, 2025 | 768.87 Mn |
| Dec 31, 2024 | 711.41 Mn |
| Mar 31, 2024 | 681.02 Mn |
| Dec 31, 2023 | 585.61 Mn |
| Sep 30, 2023 | 675.01 Mn |
| Jun 30, 2023 | 579.57 Mn |
| Mar 31, 2023 | 667.88 Mn |
| Dec 31, 2022 | 500.64 Mn |
| Sep 30, 2022 | 394.74 Mn |
| Jun 30, 2022 | 473.69 Mn |
| Mar 31, 2022 | 552.99 Mn |
| Dec 31, 2021 | 622.66 Mn |
| Sep 30, 2021 | 699.33 Mn |
| Jun 30, 2021 | 745.41 Mn |
| Mar 31, 2021 | 648.43 Mn |
| Mar 31, 2016 | 99.02 Mn |